Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

NCT03836287 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Axillary Hyperhidrosis

Interventions

DRUG: Sofpironium Bromide Gel, 15%
DRUG: Vehicle

Sponsor

Botanix Pharmaceuticals